Megan Bailey

Chief Executive Officer at Personal Genome Diagnostics, Inc.

Consumer Services

Health Technology

Profile

Megan Bailey is currently the Chief Executive Officer at Personal Genome Diagnostics, Inc. She started this position in 2020.
Ms. Bailey has a background in education, having completed her undergraduate degree at the US Military Academy and her graduate degree at the University of North Carolina System.

Megan Bailey active positions

Companies	Position	Start
Personal Genome Diagnostics, Inc. Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD.	Chief Executive Officer	20/04/2020

All active positions of Megan Bailey

Training of Megan Bailey

US Military Academy	Undergraduate Degree
University of North Carolina System	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Megan Bailey's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Personal Genome Diagnostics, Inc. Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Personal Genome Diagnostics, Inc. provides cancer genome analysis to help researchers identify cancer-related genetic changes. The firm's product PDGx develops liquid biopsy technology that uses patient-specific tumor alterations to create a simple blood test that enables tumor detection and monitoring. It provides cancer genome analyses to oncology researchers, drug developers, clinicians and patients. The company was founded by Luis A. Diaz Jr. and Victor Velculescu in 2010 and is headquartered in Baltimore, MD.	Health Technology